| Investigation on barriers to pharmaceutical care in community pharmacies: a structural equation model G Mehralian, M Rangchian, A Javadi, F Peiravian International journal of clinical pharmacy 36, 1087-1094, 2014 | 61 | 2014 |
| An analysis of job satisfaction among Iranian pharmacists through various job characteristics MJF Moghadam, F Peiravian, A Naderi, A Rajabzadeh, HR Rasekh Iranian journal of pharmaceutical research: IJPR 13 (3), 1087, 2014 | 52 | 2014 |
| Perceptions, experiences and expectations of physicians regarding the role of pharmacists in low-income and middle-income countries: the case of Tehran hospital settings F Alipour, F Peiravian, G Mehralian BMJ open 8 (2), e019237, 2018 | 28 | 2018 |
| Consumers’ perception of generic substitution in Iran N Yousefi, G Mehralian, F Peiravian, S NourMohammadi International Journal of Clinical Pharmacy 37, 497-503, 2015 | 26 | 2015 |
| The effect of organizational resilience and strategic foresight on firm performance: competitive advantage as mediating variable M Fathi, N Yousefi, H Vatanpour, F Peiravian Iranian Journal of Pharmaceutical Research: IJPR 20 (4), 497, 2021 | 24 | 2021 |
| Drug literacy in Iran: the experience of using “the single item health literacy screening (SILS) tool” F Peiravian, HR Rasekh, HJ Hashemi, N Mohammadi, N Jafari, K Fardi Iranian Journal of Pharmaceutical Research: IJPR 13 (Suppl), 217, 2014 | 24 | 2014 |
| Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration N Yousefi, N Moradi, R Dinarvand, G Ghiasi, H Inanloo, F Peiravian DARU Journal of Pharmaceutical Sciences 27, 169-177, 2019 | 20 | 2019 |
| Irrational use of antibiotics in Iran from the perspective of complex adaptive systems: redefining the challenge Z Sharif, F Peiravian, J Salamzadeh, NK Mohammadi, A Jalalimanesh BMC Public Health 21, 1-14, 2021 | 15 | 2021 |
| Out of pocket expenditures for outpatient clinics in teaching hospitals S Asefzadeh, M Alijanzadeh, F Peyravian Payesh 13 (3), 267-276, 2014 | 14 | 2014 |
| An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country A Moosivand, M Rangchian, L Zarei, F Peiravian, G Mehralian, ... Journal of Pharmaceutical Health Care and Sciences 7, 1-11, 2021 | 13 | 2021 |
| Distributor–retailer interface in pharmaceutical supply chain: service quality measurement scale G Mehralian, J Babapour Iranian journal of pharmaceutical research: IJPR 15 (4), 973, 2016 | 13 | 2016 |
| Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries A Kadkhodamanesh, V Varahrami, L Zarei, F Peiravian, M Hadidi, ... Journal of Pharmaceutical Policy and Practice 14 (1), 82, 2021 | 12 | 2021 |
| Physicians’ perceptions of generic medicine in Iran N Yousefi, G Mehralian, F Peiravian, S Jahangiri, R Ahmadi Drugs & Therapy Perspectives 31, 244-250, 2015 | 12 | 2015 |
| Generic substitution policy implementation: A pharmacists' perspective survey N Yousefi, G Mehralian, F Peiravian, F Noee Journal of generic medicines 12 (1), 17-25, 2015 | 11 | 2015 |
| An application of analytic network process model in supporting decision making to address pharmaceutical shortage L Zarei, N Moradi, F Peiravian, G Mehralian BMC health services research 20, 1-11, 2020 | 10 | 2020 |
| Country pharmaceutical situation on access, quality, and rational use of medicines: An evidence from a middle-income country H Minaei, M Peikanpour, N Yousefi, P Peymani, F Peiravian, N Shobeiri, ... Iranian Journal of Pharmaceutical Research: IJPR 18 (4), 2191, 2019 | 10 | 2019 |
| Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience B Fatemi, S Rezaei, S Taheri, F Peiravian Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 775-784, 2021 | 9 | 2021 |
| Evaluation of efficiency enhancement in Iran Health Insurance Organization: a policy brief for pharmaceutical cost containment N Yousefi, M Polroudi Moghaddam, G Afsharmanesh, F Peiravian The International Journal of Health Planning and Management 35 (6), 1503-1511, 2020 | 9 | 2020 |
| Teriparatide in the treatment of severe postmenopausal osteoporosis: a cost-utility analysis S Taheri, FM Fashami, F Peiravian, N Yousefi Iranian journal of pharmaceutical research: IJPR 18 (2), 1073, 2019 | 9 | 2019 |
| A systematic review of clinical practice guidelines for castration-resistant prostate cancer MJF Moghadam, S Taheri, F Peiravian Iranian journal of pharmaceutical research: IJPR 17 (Suppl), 17, 2018 | 9 | 2018 |
